nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlormerodrin—ALDH5A1—GABA synthesis, release, reuptake and degradation—GAD2—type 2 diabetes mellitus	0.0407	0.149	CbGpPWpGaD
Chlormerodrin—ALDH5A1—GABA synthesis, release, reuptake and degradation—SNAP25—type 2 diabetes mellitus	0.0262	0.096	CbGpPWpGaD
Chlormerodrin—ALDH5A1—Neurotransmitter Release Cycle—GAD2—type 2 diabetes mellitus	0.0216	0.079	CbGpPWpGaD
Chlormerodrin—Hyponatraemia—Tolbutamide—type 2 diabetes mellitus	0.0179	0.0275	CcSEcCtD
Chlormerodrin—Hyponatraemia—Tolazamide—type 2 diabetes mellitus	0.0163	0.025	CcSEcCtD
Chlormerodrin—Hyponatraemia—Chlorpropamide—type 2 diabetes mellitus	0.0163	0.025	CcSEcCtD
Chlormerodrin—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.0159	0.0582	CbGpPWpGaD
Chlormerodrin—ALDH5A1—Neurotransmitter Release Cycle—SNAP25—type 2 diabetes mellitus	0.0139	0.0509	CbGpPWpGaD
Chlormerodrin—ALDH5A1—nephron tubule—type 2 diabetes mellitus	0.0123	0.163	CbGeAlD
Chlormerodrin—Flatulence—Miglitol—type 2 diabetes mellitus	0.0118	0.018	CcSEcCtD
Chlormerodrin—Hyponatraemia—Glipizide—type 2 diabetes mellitus	0.0108	0.0166	CcSEcCtD
Chlormerodrin—ALDH5A1—kidney—type 2 diabetes mellitus	0.0108	0.144	CbGeAlD
Chlormerodrin—Gastrointestinal haemorrhage—Glipizide—type 2 diabetes mellitus	0.0108	0.0165	CcSEcCtD
Chlormerodrin—ALDH5A1—cortex of kidney—type 2 diabetes mellitus	0.0105	0.14	CbGeAlD
Chlormerodrin—ALDH5A1—Neuronal System—KCNK16—type 2 diabetes mellitus	0.0103	0.0378	CbGpPWpGaD
Chlormerodrin—Hyponatraemia—Glimepiride—type 2 diabetes mellitus	0.0101	0.0155	CcSEcCtD
Chlormerodrin—ALDH5A1—adipose tissue—type 2 diabetes mellitus	0.00973	0.129	CbGeAlD
Chlormerodrin—Tenderness—Irbesartan—type 2 diabetes mellitus	0.00926	0.0142	CcSEcCtD
Chlormerodrin—Flatulence—Acarbose—type 2 diabetes mellitus	0.00924	0.0142	CcSEcCtD
Chlormerodrin—Hyperkalaemia—Valsartan—type 2 diabetes mellitus	0.00924	0.0142	CcSEcCtD
Chlormerodrin—SLC12A1—nephron tubule—type 2 diabetes mellitus	0.00916	0.122	CbGeAlD
Chlormerodrin—Gastrointestinal haemorrhage—Bromocriptine—type 2 diabetes mellitus	0.00905	0.0139	CcSEcCtD
Chlormerodrin—Abdominal discomfort—Glipizide—type 2 diabetes mellitus	0.00891	0.0137	CcSEcCtD
Chlormerodrin—Hyponatraemia—Glyburide—type 2 diabetes mellitus	0.00831	0.0128	CcSEcCtD
Chlormerodrin—Abdominal discomfort—Sitagliptin—type 2 diabetes mellitus	0.00829	0.0127	CcSEcCtD
Chlormerodrin—SLC12A1—kidney—type 2 diabetes mellitus	0.00805	0.107	CbGeAlD
Chlormerodrin—Hyperkalaemia—Irbesartan—type 2 diabetes mellitus	0.00794	0.0122	CcSEcCtD
Chlormerodrin—SLC12A1—cortex of kidney—type 2 diabetes mellitus	0.00784	0.104	CbGeAlD
Chlormerodrin—Infection—Linagliptin—type 2 diabetes mellitus	0.00783	0.012	CcSEcCtD
Chlormerodrin—Abdominal discomfort—Bromocriptine—type 2 diabetes mellitus	0.0075	0.0115	CcSEcCtD
Chlormerodrin—Hyperkalaemia—Losartan—type 2 diabetes mellitus	0.00747	0.0115	CcSEcCtD
Chlormerodrin—Hyponatraemia—Gliclazide—type 2 diabetes mellitus	0.00746	0.0115	CcSEcCtD
Chlormerodrin—Gastrointestinal haemorrhage—Gliclazide—type 2 diabetes mellitus	0.00743	0.0114	CcSEcCtD
Chlormerodrin—ALDH5A1—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.00717	0.0262	CbGpPWpGaD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.00711	0.026	CbGpPWpGaD
Chlormerodrin—Hyponatraemia—Valsartan—type 2 diabetes mellitus	0.00685	0.0105	CcSEcCtD
Chlormerodrin—ALDH5A1—liver—type 2 diabetes mellitus	0.00682	0.0907	CbGeAlD
Chlormerodrin—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.00666	0.0102	CcSEcCtD
Chlormerodrin—Flatulence—Glipizide—type 2 diabetes mellitus	0.00638	0.00979	CcSEcCtD
Chlormerodrin—ALDH5A1—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.0062	0.0227	CbGpPWpGaD
Chlormerodrin—Abdominal discomfort—Gliclazide—type 2 diabetes mellitus	0.00616	0.00945	CcSEcCtD
Chlormerodrin—Rash—Miglitol—type 2 diabetes mellitus	0.00614	0.00942	CcSEcCtD
Chlormerodrin—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00613	0.00942	CcSEcCtD
Chlormerodrin—Flatulence—Pioglitazone—type 2 diabetes mellitus	0.00611	0.00938	CcSEcCtD
Chlormerodrin—Infection—Rosiglitazone—type 2 diabetes mellitus	0.006	0.00921	CcSEcCtD
Chlormerodrin—Flatulence—Sitagliptin—type 2 diabetes mellitus	0.00594	0.00911	CcSEcCtD
Chlormerodrin—Hyponatraemia—Irbesartan—type 2 diabetes mellitus	0.00589	0.00904	CcSEcCtD
Chlormerodrin—Nausea—Miglitol—type 2 diabetes mellitus	0.00578	0.00888	CcSEcCtD
Chlormerodrin—Abdominal discomfort—Orlistat—type 2 diabetes mellitus	0.00559	0.00858	CcSEcCtD
Chlormerodrin—Hyponatraemia—Losartan—type 2 diabetes mellitus	0.00554	0.00851	CcSEcCtD
Chlormerodrin—Rash—Tolbutamide—type 2 diabetes mellitus	0.00552	0.00847	CcSEcCtD
Chlormerodrin—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00545	0.00837	CcSEcCtD
Chlormerodrin—ALDH5A1—Neuronal System—ABCC8—type 2 diabetes mellitus	0.00543	0.0199	CbGpPWpGaD
Chlormerodrin—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00539	0.00828	CcSEcCtD
Chlormerodrin—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00524	0.00804	CcSEcCtD
Chlormerodrin—Nausea—Tolbutamide—type 2 diabetes mellitus	0.0052	0.00798	CcSEcCtD
Chlormerodrin—Abdominal discomfort—Metformin—type 2 diabetes mellitus	0.00515	0.00791	CcSEcCtD
Chlormerodrin—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.00512	0.0187	CbGpPWpGaD
Chlormerodrin—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00506	0.00777	CcSEcCtD
Chlormerodrin—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00505	0.00775	CcSEcCtD
Chlormerodrin—Infection—Pioglitazone—type 2 diabetes mellitus	0.00503	0.00772	CcSEcCtD
Chlormerodrin—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00502	0.00771	CcSEcCtD
Chlormerodrin—Rash—Tolazamide—type 2 diabetes mellitus	0.00502	0.00771	CcSEcCtD
Chlormerodrin—Rash—Linagliptin—type 2 diabetes mellitus	0.00497	0.00763	CcSEcCtD
Chlormerodrin—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00497	0.00762	CcSEcCtD
Chlormerodrin—Infection—Sitagliptin—type 2 diabetes mellitus	0.00488	0.0075	CcSEcCtD
Chlormerodrin—Vomiting—Acarbose—type 2 diabetes mellitus	0.00487	0.00747	CcSEcCtD
Chlormerodrin—Rash—Acarbose—type 2 diabetes mellitus	0.00483	0.00741	CcSEcCtD
Chlormerodrin—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00482	0.0074	CcSEcCtD
Chlormerodrin—Hyponatraemia—Ramipril—type 2 diabetes mellitus	0.00475	0.0073	CcSEcCtD
Chlormerodrin—ALDH5A1—Neuronal System—GAD2—type 2 diabetes mellitus	0.00475	0.0174	CbGpPWpGaD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.00475	0.0174	CbGpPWpGaD
Chlormerodrin—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00473	0.00726	CcSEcCtD
Chlormerodrin—Nausea—Tolazamide—type 2 diabetes mellitus	0.00473	0.00726	CcSEcCtD
Chlormerodrin—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00469	0.0072	CcSEcCtD
Chlormerodrin—Rash—Nateglinide—type 2 diabetes mellitus	0.00465	0.00714	CcSEcCtD
Chlormerodrin—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00465	0.00714	CcSEcCtD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.00458	0.0168	CbGpPWpGaD
Chlormerodrin—Nausea—Acarbose—type 2 diabetes mellitus	0.00455	0.00698	CcSEcCtD
Chlormerodrin—Infection—Bromocriptine—type 2 diabetes mellitus	0.00442	0.00678	CcSEcCtD
Chlormerodrin—Flatulence—Gliclazide—type 2 diabetes mellitus	0.00441	0.00677	CcSEcCtD
Chlormerodrin—Nausea—Nateglinide—type 2 diabetes mellitus	0.00438	0.00673	CcSEcCtD
Chlormerodrin—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00437	0.00671	CcSEcCtD
Chlormerodrin—ALDH5A1—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.00429	0.0157	CbGpPWpGaD
Chlormerodrin—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00413	0.00634	CcSEcCtD
Chlormerodrin—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00406	0.00623	CcSEcCtD
Chlormerodrin—Flatulence—Valsartan—type 2 diabetes mellitus	0.00405	0.00622	CcSEcCtD
Chlormerodrin—Rash—Repaglinide—type 2 diabetes mellitus	0.00403	0.00618	CcSEcCtD
Chlormerodrin—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00402	0.00618	CcSEcCtD
Chlormerodrin—Flatulence—Orlistat—type 2 diabetes mellitus	0.004	0.00614	CcSEcCtD
Chlormerodrin—ALDH5A1—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.00399	0.0146	CbGpPWpGaD
Chlormerodrin—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.00392	0.00602	CcSEcCtD
Chlormerodrin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00381	0.00584	CcSEcCtD
Chlormerodrin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.0038	0.00584	CcSEcCtD
Chlormerodrin—Nausea—Repaglinide—type 2 diabetes mellitus	0.00379	0.00582	CcSEcCtD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.00374	0.0137	CbGpPWpGaD
Chlormerodrin—Flatulence—Metformin—type 2 diabetes mellitus	0.00369	0.00566	CcSEcCtD
Chlormerodrin—Infection—Gliclazide—type 2 diabetes mellitus	0.00363	0.00557	CcSEcCtD
Chlormerodrin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00362	0.00555	CcSEcCtD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.00361	0.0132	CbGpPWpGaD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.0036	0.0132	CbGpPWpGaD
Chlormerodrin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00359	0.0055	CcSEcCtD
Chlormerodrin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00352	0.0054	CcSEcCtD
Chlormerodrin—Flatulence—Irbesartan—type 2 diabetes mellitus	0.00348	0.00534	CcSEcCtD
Chlormerodrin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00346	0.00532	CcSEcCtD
Chlormerodrin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00337	0.00518	CcSEcCtD
Chlormerodrin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00336	0.00516	CcSEcCtD
Chlormerodrin—Vomiting—Glipizide—type 2 diabetes mellitus	0.00336	0.00516	CcSEcCtD
Chlormerodrin—Infection—Valsartan—type 2 diabetes mellitus	0.00333	0.00512	CcSEcCtD
Chlormerodrin—Rash—Glipizide—type 2 diabetes mellitus	0.00333	0.00511	CcSEcCtD
Chlormerodrin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00333	0.00511	CcSEcCtD
Chlormerodrin—Infection—Orlistat—type 2 diabetes mellitus	0.00329	0.00506	CcSEcCtD
Chlormerodrin—Flatulence—Losartan—type 2 diabetes mellitus	0.00328	0.00503	CcSEcCtD
Chlormerodrin—Nausea—Glipizide—type 2 diabetes mellitus	0.00314	0.00482	CcSEcCtD
Chlormerodrin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00314	0.00481	CcSEcCtD
Chlormerodrin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00313	0.0048	CcSEcCtD
Chlormerodrin—Rash—Glimepiride—type 2 diabetes mellitus	0.00311	0.00477	CcSEcCtD
Chlormerodrin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00311	0.00477	CcSEcCtD
Chlormerodrin—Rash—Sitagliptin—type 2 diabetes mellitus	0.0031	0.00476	CcSEcCtD
Chlormerodrin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.0031	0.00475	CcSEcCtD
Chlormerodrin—ALDH5A1—Neuronal System—SNAP25—type 2 diabetes mellitus	0.00306	0.0112	CbGpPWpGaD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.00306	0.0112	CbGpPWpGaD
Chlormerodrin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00304	0.00467	CcSEcCtD
Chlormerodrin—Infection—Metformin—type 2 diabetes mellitus	0.00304	0.00466	CcSEcCtD
Chlormerodrin—ALDH5A1—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.00298	0.0109	CbGpPWpGaD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.00295	0.0108	CbGpPWpGaD
Chlormerodrin—Nausea—Glimepiride—type 2 diabetes mellitus	0.00293	0.0045	CcSEcCtD
Chlormerodrin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00292	0.00448	CcSEcCtD
Chlormerodrin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00289	0.00443	CcSEcCtD
Chlormerodrin—Infection—Irbesartan—type 2 diabetes mellitus	0.00286	0.0044	CcSEcCtD
Chlormerodrin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00283	0.00434	CcSEcCtD
Chlormerodrin—Rash—Bromocriptine—type 2 diabetes mellitus	0.00281	0.00431	CcSEcCtD
Chlormerodrin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.0028	0.0043	CcSEcCtD
Chlormerodrin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00278	0.00427	CcSEcCtD
Chlormerodrin—Infection—Losartan—type 2 diabetes mellitus	0.0027	0.00414	CcSEcCtD
Chlormerodrin—ALDH5A1—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.00266	0.00973	CbGpPWpGaD
Chlormerodrin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00264	0.00406	CcSEcCtD
Chlormerodrin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00262	0.00402	CcSEcCtD
Chlormerodrin—Vomiting—Glyburide—type 2 diabetes mellitus	0.00259	0.00397	CcSEcCtD
Chlormerodrin—Rash—Glyburide—type 2 diabetes mellitus	0.00256	0.00394	CcSEcCtD
Chlormerodrin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00256	0.00393	CcSEcCtD
Chlormerodrin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.0025	0.00384	CcSEcCtD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.00246	0.00899	CbGpPWpGaD
Chlormerodrin—Nausea—Glyburide—type 2 diabetes mellitus	0.00242	0.00371	CcSEcCtD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.00241	0.00882	CbGpPWpGaD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.00235	0.00858	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.00233	0.00852	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.00233	0.00852	CbGpPWpGaD
Chlormerodrin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00232	0.00356	CcSEcCtD
Chlormerodrin—Rash—Gliclazide—type 2 diabetes mellitus	0.0023	0.00353	CcSEcCtD
Chlormerodrin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.0023	0.00353	CcSEcCtD
Chlormerodrin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.0023	0.00352	CcSEcCtD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.00229	0.00838	CbGpPWpGaD
Chlormerodrin—ALDH5A1—Neuronal System—GNB3—type 2 diabetes mellitus	0.00229	0.00836	CbGpPWpGaD
Chlormerodrin—ALDH5A1—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.00228	0.00836	CbGpPWpGaD
Chlormerodrin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00228	0.0035	CcSEcCtD
Chlormerodrin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00227	0.00348	CcSEcCtD
Chlormerodrin—Nausea—Gliclazide—type 2 diabetes mellitus	0.00217	0.00333	CcSEcCtD
Chlormerodrin—ALDH5A1—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.00215	0.00785	CbGpPWpGaD
Chlormerodrin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00215	0.00329	CcSEcCtD
Chlormerodrin—Vomiting—Valsartan—type 2 diabetes mellitus	0.00213	0.00327	CcSEcCtD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.00213	0.00779	CbGpPWpGaD
Chlormerodrin—Rash—Valsartan—type 2 diabetes mellitus	0.00212	0.00325	CcSEcCtD
Chlormerodrin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00211	0.00324	CcSEcCtD
Chlormerodrin—Vomiting—Orlistat—type 2 diabetes mellitus	0.00211	0.00324	CcSEcCtD
Chlormerodrin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00209	0.00321	CcSEcCtD
Chlormerodrin—Rash—Orlistat—type 2 diabetes mellitus	0.00209	0.00321	CcSEcCtD
Chlormerodrin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00209	0.00321	CcSEcCtD
Chlormerodrin—ALDH5A1—Neuronal System—ADCY5—type 2 diabetes mellitus	0.00204	0.00745	CbGpPWpGaD
Chlormerodrin—Nausea—Valsartan—type 2 diabetes mellitus	0.00199	0.00306	CcSEcCtD
Chlormerodrin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00197	0.00303	CcSEcCtD
Chlormerodrin—Nausea—Orlistat—type 2 diabetes mellitus	0.00197	0.00302	CcSEcCtD
Chlormerodrin—Vomiting—Metformin—type 2 diabetes mellitus	0.00194	0.00298	CcSEcCtD
Chlormerodrin—Rash—Metformin—type 2 diabetes mellitus	0.00193	0.00296	CcSEcCtD
Chlormerodrin—Dermatitis—Metformin—type 2 diabetes mellitus	0.00192	0.00295	CcSEcCtD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.0019	0.00696	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.0019	0.00694	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.0019	0.00694	CbGpPWpGaD
Chlormerodrin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00186	0.00285	CcSEcCtD
Chlormerodrin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00184	0.00282	CcSEcCtD
Chlormerodrin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00183	0.00281	CcSEcCtD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.00183	0.00668	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.00183	0.00668	CbGpPWpGaD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.00182	0.00667	CbGpPWpGaD
Chlormerodrin—Rash—Irbesartan—type 2 diabetes mellitus	0.00182	0.00279	CcSEcCtD
Chlormerodrin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00182	0.00279	CcSEcCtD
Chlormerodrin—Nausea—Metformin—type 2 diabetes mellitus	0.00181	0.00279	CcSEcCtD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.0018	0.00657	CbGpPWpGaD
Chlormerodrin—ALDH5A1—Neuronal System—CALM1—type 2 diabetes mellitus	0.00175	0.0064	CbGpPWpGaD
Chlormerodrin—Vomiting—Losartan—type 2 diabetes mellitus	0.00173	0.00265	CcSEcCtD
Chlormerodrin—Nausea—Irbesartan—type 2 diabetes mellitus	0.00171	0.00263	CcSEcCtD
Chlormerodrin—Rash—Losartan—type 2 diabetes mellitus	0.00171	0.00263	CcSEcCtD
Chlormerodrin—Dermatitis—Losartan—type 2 diabetes mellitus	0.00171	0.00262	CcSEcCtD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.00166	0.00607	CbGpPWpGaD
Chlormerodrin—ALDH5A1—Neuronal System—PRKCB—type 2 diabetes mellitus	0.00165	0.00602	CbGpPWpGaD
Chlormerodrin—Nausea—Losartan—type 2 diabetes mellitus	0.00161	0.00247	CcSEcCtD
Chlormerodrin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00159	0.00244	CcSEcCtD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.00155	0.00568	CbGpPWpGaD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.00155	0.00567	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.0015	0.00549	CbGpPWpGaD
Chlormerodrin—Vomiting—Ramipril—type 2 diabetes mellitus	0.00148	0.00227	CcSEcCtD
Chlormerodrin—Rash—Ramipril—type 2 diabetes mellitus	0.00147	0.00225	CcSEcCtD
Chlormerodrin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00147	0.00225	CcSEcCtD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.00144	0.00526	CbGpPWpGaD
Chlormerodrin—Nausea—Ramipril—type 2 diabetes mellitus	0.00138	0.00212	CcSEcCtD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.00125	0.00457	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.00119	0.00436	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.00119	0.00436	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.00116	0.00426	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.00116	0.00423	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.00115	0.00421	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.00101	0.00371	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000967	0.00354	CbGpPWpGaD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	0.00094	0.00344	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000927	0.00339	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000799	0.00292	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000795	0.00291	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000788	0.00288	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000762	0.00279	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000712	0.00261	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000643	0.00235	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000603	0.0022	CbGpPWpGaD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000478	0.00175	CbGpPWpGaD
